Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer
Authors:
- 1 September 2014
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 15 (10) , 1168-1176
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK (grant numbers C5547/A7375 and C25786/A10093)
This publication has 28 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trialThe Lancet Oncology, 2011
- The Association of Depression and Pain with Health-Related Quality of Life, Disability, and Health Care Use in Cancer PatientsJournal of Pain and Symptom Management, 2010
- Effect of Telecare Management on Pain and Depression in Patients With CancerJAMA, 2010
- Meaning‐centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trialPsycho-Oncology, 2009
- The third Symptom Management Research Trial in Oncology (SMaRT Oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (Depression Care for People with Lung Cancer) to usual care, compared to usual care alone in patients with lung cancerTrials, 2009
- Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With CancerJournal of Clinical Oncology, 2008
- The PHQ-9Journal of General Internal Medicine, 2001
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Analysis of serial measurements in medical research.BMJ, 1990